HC Wainwright & Co. Reiterates Buy on Pulmatrix, Maintains $10 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on Pulmatrix (NASDAQ:PULM) and maintained a $10 price target.
August 15, 2023 | 10:49 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated a 'Buy' rating on Pulmatrix, maintaining a $10 price target.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for Pulmatrix. The maintained price target of $10 also indicates the firm's continued confidence in the stock's potential, which could positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100